相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。High-cholesterol diet promotes depression- and anxiety-like behaviors in mice by impact gut microbe and neuroinflammation
Lili Zou et al.
JOURNAL OF AFFECTIVE DISORDERS (2023)
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
Madia Lozupone et al.
ALZHEIMERS & DEMENTIA (2023)
SIRT1 pathway in Parkinson's disease: a faraway snapshot but so close
Gaber El-Saber Batiha et al.
INFLAMMOPHARMACOLOGY (2023)
Impact of dyslipidemia in the development of cardiovascular complications: Delineating the potential therapeutic role of coenzyme
Sinenhlanhla X. H. Mthembu et al.
BIOCHIMIE (2023)
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects
Mohammed Alrouji et al.
INFLAMMOPHARMACOLOGY (2023)
Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
Hayder M. M. Al-kuraishy et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2023)
Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis
Solenne Vigne et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Brain cell type-specific cholesterol metabolism and implications for learning and memory
Dingfeng Li et al.
TRENDS IN NEUROSCIENCES (2022)
Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson's Disease Mouse Models
Jung-Eun Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Intravenous 2-hydroxypropyl-β-cyclodextrin (Trappsol® Cyclo™) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and peripheral tissues in adult subjects with Niemann-Pick Disease Type C1: Results of a phase 1 trial
Caroline Hastings et al.
MOLECULAR GENETICS AND METABOLISM (2022)
Relationship between Brain Metabolic Disorders and Cognitive Impairment: LDL Receptor Defect
Dong-Yong Hong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
High cholesterol and 27-hydroxycholesterol contribute to phosphorylation of tau protein by impairing autophagy causing learning and memory impairment in C57BL/6J mice
Tao Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2022)
Role of reactive oxygen species in regulating 27-hydroxycholesterol-induced apoptosis of hematopoietic progenitor cells and myeloid cell lines
Soo-Yeon Woo et al.
CELL DEATH & DISEASE (2022)
Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease
Janelle Drouin-Ouellet et al.
STEM CELL REPORTS (2022)
Liver X Receptor Regulation of Glial Cell Functions in the CNS
Xiaoyu Song et al.
BIOMEDICINES (2022)
Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer's Disease
Shwetha Nanjundaiah et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)
The Non-Motor Symptoms Scale in Parkinson's disease: Validation and use
Daniel J. van Wamelen et al.
ACTA NEUROLOGICA SCANDINAVICA (2021)
Lipid metabolism in astrocytic structure and function
James A. K. Lee et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease
Tapan Behl et al.
MOLECULAR NEUROBIOLOGY (2021)
The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
Patricia Garcia-Sanz et al.
MOVEMENT DISORDERS (2021)
Visceral adipose tissue had a causal, independent role in lowering the risk of Parkinson's disease: A mendelian randomization study
Yaozhong Liu et al.
PARKINSONISM & RELATED DISORDERS (2021)
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation
Federica Bono et al.
NEUROBIOLOGY OF AGING (2021)
Effects of statins on mitochondrial pathways
Hamid Mollazadeh et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)
Cholesterol-recognition motifs in the transmembrane domain of the tyrosine kinase receptor family: The case of TRKB
Cecilia Cannarozzo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
Parkinson's disease
Bastiaan R. Bloem et al.
LANCET (2021)
The thrombin receptor links brain derived neurotrophic factor to neuron cholesterol production, resiliency and repair after spinal cord injury
Erin M. Triplet et al.
NEUROBIOLOGY OF DISEASE (2021)
Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia
Chao Wang et al.
NEURON (2021)
Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
Frank C. Church
BIOMOLECULES (2021)
Testosterone in COVID-19: An Adversary Bane or Comrade Boon
Hayder M. Al-kuraishy et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
SR-B1, a Key Receptor Involved in the Progression of Cardiovascular Disease: A Perspective from Mice and Human Genetic Studies
Irene Gracia-Rubio et al.
BIOMEDICINES (2021)
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
David K. Simon et al.
CLINICS IN GERIATRIC MEDICINE (2020)
Parkinson disease
R. Balestrino et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
GABAergic changes in the thalamocortical circuit in Parkinson's disease
Annelies J. M. van Nuland et al.
HUMAN BRAIN MAPPING (2020)
Management of Dysphagia in Patients with Parkinson's Disease and Related Disorders
George Umemoto et al.
INTERNAL MEDICINE (2020)
Mitochondrial bioenergetics and redox dysfunctions in hypercholesterolemia and atherosclerosis
Helena C. F. Oliveira et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
A Role of Cholesterol in Modulating the Binding of α-Synuclein to Synaptic-Like Vesicles
Wing K. Man et al.
FRONTIERS IN NEUROSCIENCE (2020)
Endoplasmic reticulum stress, an important factor in the development of Parkinson's disease
Zheng Mou et al.
TOXICOLOGY LETTERS (2020)
ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity
Mateo Amaya-Montoya et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Potassium channels and their emerging role in parkinson's disease
Linlin Zhang et al.
BRAIN RESEARCH BULLETIN (2020)
Effects of Higher Serum Lipid Levels on the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
Zheng Jiang et al.
FRONTIERS IN NEUROLOGY (2020)
Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson's Disease
Yanxuan Li et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson's Disease
Helena Xicoy et al.
CELLS (2020)
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
Maria Teresa Bilotta et al.
FRONTIERS IN IMMUNOLOGY (2020)
Statins role in vitiligo: A mini-review
Hayder M. Al-Kuraishy et al.
TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY (2020)
Serum level of brain-derived neurotrophic factor in Parkinson's disease: a meta-analysis
Lina Jiang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Bruno Lima Giacobbo et al.
MOLECULAR NEUROBIOLOGY (2019)
Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: A systematic review and meta-analysis
Farzaneh Rahmani et al.
BRAIN RESEARCH (2019)
Computational insights into the interaction mechanisms of estrogen-related receptor alpha with endogenous ligand cholesterol
Dongping Li et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Cholesterol and the Safety Factor for Neuromuscular Transmission
Igor I. Krivoi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment
Ranl Loera-Valencia et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
Effect of statins on Parkinson's disease A systematic review and meta-analysis
Junqiang Yan et al.
MEDICINE (2019)
Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
Jessica Camacho et al.
FRONTIERS IN NEUROLOGY (2019)
Lipid Metabolism Crosstalk in the Brain: Glia and Neurons
Casey N. Barber et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson's Disease
Irina Alecu et al.
FRONTIERS IN NEUROSCIENCE (2019)
The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease
Shayan Moosa et al.
MOVEMENT DISORDERS (2019)
Liver X Receptor Alpha Is Important in Maintaining Blood-Brain Barrier Function
Elien Wouters et al.
FRONTIERS IN IMMUNOLOGY (2019)
Lipids, Apolipoproteins, and the Risk of Parkinson Disease A Prospective Cohort Study and a Mendelian Randomization Analysis
Fang Fang et al.
CIRCULATION RESEARCH (2019)
Regulation of Brain Cholesterol: What Role Do Liver X Receptors Play in Neurodegenerative Diseases?
Kevin Mouzat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease
Shirley Yin-Yu Pang et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Trends in the incidence and prevalence of Parkinson's disease in Korea: a nationwide, population-based study
Joo-Hyun Park et al.
BMC GERIATRICS (2019)
Brain-derived neurotrophic factor modulates cholesterol homeostasis and Apolipoprotein E synthesis in human cell models of astrocytes and neurons
Maria S. Spagnuolo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Higher Serum Cholesterol and Decreased Parkinson's Disease Risk: A Statin-Free Cohort Study
Violetta Rozani et al.
MOVEMENT DISORDERS (2018)
Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study
Ga Eun Nam et al.
PLOS MEDICINE (2018)
Neuroinflammation pathways: a general review
Tara Shabab et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Can Cholesterol Metabolism Modulation Affect Brain Function and Behavior?
Veronica Cartocci et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
The mevalonate pathway in neurons: It's not just about cholesterol
Miguel Moutinho et al.
EXPERIMENTAL CELL RESEARCH (2017)
A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus
Sylwia W. Brooks et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
α-Synuclein Regulates Neuronal Cholesterol Efflux
Jen-Hsiang T. Hsiao et al.
MOLECULES (2017)
Statins May Facilitate Parkinson's Disease: Insight Gained From a Large, National Claims Database
Guodong Liu et al.
MOVEMENT DISORDERS (2017)
Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson's disease
Rajib Paul et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study
Marianne Benn et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study
Marianne Benn et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Cholesterol crystals enhance TLR2-and TLR4-mediated pro-inflammatory cytokine responses of monocytes to the proatherogenic oral bacterium Porphyromonas gingivalis
Tania Kollgaard et al.
PLOS ONE (2017)
Dietary habits and neurological features of Parkinson's disease patients: Implications for practice
Michela Barichella et al.
CLINICAL NUTRITION (2017)
Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis
Ahmed Negida et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2016)
Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease
Margaux Doria et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes
Simon Zhornitsky et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
The biomarkers of immune dysregulation and inflammation response in Parkinson disease
Li Chen et al.
TRANSLATIONAL NEURODEGENERATION (2016)
Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?
Gurdeep Marwarha et al.
EXPERIMENTAL GERONTOLOGY (2015)
Cholesterol facilitates interactions between α-synuclein oligomers and charge-neutral membranes
Andreas van Maarschalkerweerd et al.
FEBS LETTERS (2015)
Cholesterol under oxidative stress-How lipid membranes sense oxidation as cholesterol is being replaced by oxysterols
Waldemar Kulig et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells
Juhee Lim et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Statins, Plasma Cholesterol, and Risk of Parkinson's Disease: A Prospective Study
Xuemei Huang et al.
MOVEMENT DISORDERS (2015)
Oxidative stress and Parkinson's disease
Javier Blesa et al.
FRONTIERS IN NEUROANATOMY (2015)
Cholesterol metabolism and homeostasis in the brain
Juan Zhang et al.
PROTEIN & CELL (2015)
The serum lipid profile of Parkinson's disease patients: a study from China
Xiaoyan Guo et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease
Krithika Muthukumaran et al.
BMC NEUROSCIENCE (2014)
Association of glycogen synthase kinase-3β with Parkinson's disease (Review)
Da-Wei Li et al.
MOLECULAR MEDICINE REPORTS (2014)
Inflammatory response in Parkinson's disease
Junqiang Yan et al.
MOLECULAR MEDICINE REPORTS (2014)
Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease
Marianna Sikorska et al.
NEUROBIOLOGY OF AGING (2014)
Neuroinflammation: The role and consequences
Monty Lyman et al.
NEUROSCIENCE RESEARCH (2014)
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease No Evidence of Benefit
M. Flint Beal et al.
JAMA NEUROLOGY (2014)
Cholesterol binding to ion channels
Irena Levitan et al.
FRONTIERS IN PHYSIOLOGY (2014)
Brain Cholesterol Metabolism, Oxysterols, and Dementia
Timothy M. Hughes et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies
Krishna Undela et al.
JOURNAL OF NEUROLOGY (2013)
Effects of squalene/squalane on dopamine levels, antioxidant enzyme activity, and fatty acid composition in the striatum of Parkinson's disease mouse model
Hideaki Kabuto et al.
JOURNAL OF OLEO SCIENCE (2013)
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease
S. Iannaccone et al.
PARKINSONISM & RELATED DISORDERS (2013)
The neuroprotective roles of BDNF in hypoxic ischemic brain injury (Review)
Ai Chen et al.
BIOMEDICAL REPORTS (2013)
Role of Serum Cholesterol in Parkinson's Disease: A Meta-Analysis of Evidence
Kapil Gudala et al.
JOURNAL OF PARKINSONS DISEASE (2013)
Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease
L. Lim et al.
CELL DEATH AND DIFFERENTIATION (2012)
Olfactory dysfunction in Parkinson disease
Richard L. Doty
NATURE REVIEWS NEUROLOGY (2012)
Sodium Phenylbutyrate Controls Neuroinflammatory and Antioxidant Activities and Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease
Avik Roy et al.
PLOS ONE (2012)
Interleukin-6 Protects Human Macrophages from Cellular Cholesterol Accumulation and Attenuates the Proinflammatory Response
Eric Frisdal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors-relevance to Parkinson's disease
Gurdeep Marwarha et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Prospects of Statins in Parkinson Disease
Avik Roy et al.
NEUROSCIENTIST (2011)
Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study
Emma Aden et al.
NUTRITIONAL NEUROSCIENCE (2011)
Neuroinflammation in Parkinson's disease
Etienne C. Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2011)
Silencing GADD153/CHOP Gene Expression Protects against Alzheimer's Disease-Like Pathology Induced by 27-Hydroxycholesterol in Rabbit Hippocampus
Jaya R. P. Prasanthi et al.
PLOS ONE (2011)
Lipopolysaccharide Animal Models for Parkinson's Disease
Mei Liu et al.
PARKINSONS DISEASE (2011)
Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies
Andrew O. Koob et al.
EXPERIMENTAL NEUROLOGY (2010)
Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease
Paula Scalzo et al.
JOURNAL OF NEUROLOGY (2010)
Neuroplasticity - Exercise-Induced Response of Peripheral Brain-Derived Neurotrophic Factor A Systematic Review of Experimental Studies in Human Subjects
Kristel Knaepen et al.
SPORTS MEDICINE (2010)
The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells
Bhanu Dasari et al.
BMC OPHTHALMOLOGY (2010)
Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors
M. Futter et al.
JOURNAL OF MEDICAL GENETICS (2009)
Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats
Katja Nieweg et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The role of α-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response
Mikhail Y. Golovko et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Medical records documentation of constipation preceding Parkinson disease A case-control study
R. Savica et al.
NEUROLOGY (2009)
Nourishing and health benefits of coenzyme Q(10) - a review
Martina Borekova et al.
CZECH JOURNAL OF FOOD SCIENCES (2008)
High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice
L. Thirumangalakudi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Total cholesterol and the risk of Parkinson disease
G. Hu et al.
NEUROLOGY (2008)
Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Claire Henchcliffe et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Kelly Claire Simon et al.
NEUROLOGY (2007)
Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development
Shingo Suzuki et al.
JOURNAL OF NEUROSCIENCE (2007)
Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations
Hemmi N. Bhagavan et al.
MITOCHONDRION (2007)
Serum cholesterol changes after midlife and late-life cognition -: Twenty-one-year follow-up study
A. Solomon et al.
NEUROLOGY (2007)
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease
Xuemei Huang et al.
MOVEMENT DISORDERS (2007)
Survival of adult neurons lacking cholesterol synthesis in vivo
Ursula Fuenfschilling et al.
BMC NEUROSCIENCE (2007)
Inhibition of glycogen synthase kinase-3 beta protects doparninergic neurons from MPTP toxicity
Wenya Wang et al.
NEUROPHARMACOLOGY (2007)
Serum cholesterol levels and the risk of Parkinson's disease
Lonneke M. L. de lau et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate α-synuclein fibrilization
DA Bosco et al.
NATURE CHEMICAL BIOLOGY (2006)
Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons
P Kooncumchoo et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2006)
Therapeutic role of coenzyme Q10 in Parkinson's disease
CW Shults
PHARMACOLOGY & THERAPEUTICS (2005)
Dietary fatty acids and the risk of Parkinson disease - The Rotterdam study
LML de Lau et al.
NEUROLOGY (2005)
Pathogenesis of nigral cell death in Parkinson's disease
S Przedborski
PARKINSONISM & RELATED DISORDERS (2005)
Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone:: protective effect of coenzyme Q10
Y Moon et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10
M Somayajulu et al.
NEUROBIOLOGY OF DISEASE (2005)
Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease
AB Reiss et al.
NEUROBIOLOGY OF AGING (2004)
Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease
M Sohmiya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Lipid rafts mediate the synaptic localization of α-synuclein
DL Fortin et al.
JOURNAL OF NEUROSCIENCE (2004)
APOE-ε2 allele associated with higher prevalence of sporadic Parkinson disease
XM Huang et al.
NEUROLOGY (2004)
Uptake and transport of high-density lipoprotein (HDL) and HDL-associated α-tocopherol by an in vitro blood-brain barrier model
Z Balazs et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Role of cholesterol in lipid raft formation: lessons from lipid model systems
JR Silvius
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Combination of serum markers related to several mechanisms in Alzheimer's disease
CE Teunissen et al.
NEUROBIOLOGY OF AGING (2003)
Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease
M Kivipelto et al.
ANNALS OF INTERNAL MEDICINE (2002)
α-synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins
R Sharon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease
MG Murer et al.
PROGRESS IN NEUROBIOLOGY (2001)